Dabur India gets NCLT approval for Sesa Care merger 2026

Introduction

Dabur India has received a key legal clearance for its proposed amalgamation of Sesa Care Private Limited with the listed FMCG company. The National Company Law Tribunal (NCLT), New Delhi Bench sanctioned the Scheme of Amalgamation at a hearing held on September 24, 2026. Dabur subsequently informed stock exchanges through regulatory filings, and also shared the NCLT order with BSE and NSE. The merger is being executed under Sections 230 to 232 of the Companies Act, 2013. While the sanction is a major milestone, the company said the merger will become effective only after completing required statutory filings and other conditions under the scheme.

What the NCLT approved

The NCLT’s sanction covers the Scheme of Amalgamation under which Sesa Care will be merged with and into Dabur India. This is the judicial approval that generally gives legal effect to a court-supervised merger process under the Companies Act framework. Dabur described the approval as a key milestone for integrating Sesa Care, a premium Ayurvedic hair care brand, into its portfolio. The company indicated the integration is subject to procedural completion rather than automatic on the date of the tribunal order. The scheme’s appointed date is April 1, 2026, which is typically the date from which the amalgamation is accounted for as per scheme terms.

Key dates and disclosures to stock exchanges

The NCLT pronounced the order on September 24, 2026, according to Dabur’s disclosure. Dabur also stated it uploaded the order to stock exchanges after receiving it. Reports around the exchange update indicate the company uploaded the NCLT order on September 26, 2026, after the tribunal pronounced it two days earlier. Separately, a market snapshot referenced September 25, 2026 as the date Dabur announced the approval to exchanges, consistent with “Friday” trade references in market coverage. Across the disclosures, the central point remains that NCLT sanction has been received, and the remaining steps are statutory filings and completion of conditions.

What Dabur has already completed in the process

Dabur said the proposed amalgamation had already received approvals from its equity shareholders and unsecured creditors. These approvals were obtained at meetings convened pursuant to NCLT directions dated May 2, 2026. Dabur also noted that approvals from relevant regulatory authorities had been received before the final tribunal sanction. With the NCLT order now in place, the transaction moves from regulatory review to execution steps. The company reiterated that effectiveness depends on completing required filings and formalities stipulated under the scheme.

Background: transaction announced in 2024

Dabur indicated that the transaction was first announced in October 2024. It also disclosed that it had acquired a 51% stake in Sesa Care from True North in October 2024. The board approved the merger scheme in May 2025, as referenced in the reporting around the tribunal order. The NCLT sanction in September 2026 is positioned as the culmination of the court-supervised approval track. The integration is framed around bringing the premium Ayurvedic hair care brand into Dabur’s listed operations.

Why the merger matters for Dabur’s portfolio

The consolidation formally brings Sesa Care into Dabur’s portfolio and is aimed at strengthening presence in the value-added hair oil segment, as described in the market snapshot. The scheme also moves Dabur from its earlier majority ownership structure toward full amalgamation, absorbing the entity into Dabur India. For investors, the key near-term consideration is procedural completion rather than a new announcement of intent, because the scheme has now been sanctioned. The company’s repeated emphasis on statutory filings signals the remaining checklist items before the merger becomes effective.

Market reaction: stock traded marginally lower

Following the disclosure that NCLT had approved the merger, Dabur India shares were reported to be trading marginally lower in Friday’s trade. At the latest check cited in the report, Dabur India shares were down 0.19% at Rs 384.40. The move suggests the update was treated largely as a process milestone rather than an unexpected event, given the merger had been previously announced. Market participants also tend to focus on whether any additional approvals or conditions could affect timelines, which Dabur addressed by noting the need for statutory filings.

Snapshot of key facts

What happens next

Dabur said the merger will become effective only upon completion of necessary statutory filings and satisfaction of other conditions stipulated under the scheme. In practical terms, this means the legal sanction has been received, but procedural steps still need to be completed before the amalgamation is implemented. Dabur has also indicated it will continue to keep stock exchanges informed through filings as the process progresses. The next updates are therefore expected around completion of statutory filings and confirmation that the scheme has become effective.

Conclusion

The NCLT New Delhi Bench’s order dated September 24, 2026 is the key regulatory clearance for Dabur India’s amalgamation of Sesa Care. Dabur has since shared the development with stock exchanges and reiterated that effectiveness depends on statutory filings and scheme conditions. The appointed date of April 1, 2026 remains central to how the amalgamation is accounted for under the scheme once it becomes effective. Investors will likely track the company’s subsequent filings confirming completion of the remaining formalities and the effective date of the merger.